Latest News and Press Releases

BERLIN, Germany, Oct. 16, 2001 (PRIMEZONE) -- atugen AG and AstraZeneca PLC (NYSE:AZN) today announced a broad collaboration to utilize atugen's GeneBloc(R) technology to enhance the efficiency of...

CAMBRIDGE, UK, Sept. 20, 2001 (PRIMEZONE) -- Acambis plc ("Acambis"), (LSE:ACM) (Nasdaq:ACAM), announces that it has successfully completed a Phase II challenge trial of its ChimeriVax-JE vaccine...

CAMBRIDGE, UK, Sept. 20, 2001 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM), announces its interim results for the six months ended June 30, 2001. Highlights: Significant...

CAMBRIDGE, UK, Sept. 19, 2001 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM), announces that it has selected a vaccine candidate for the prevention of West Nile encephalitis in...

BERLIN, Germany, Sept. 10, 2001 (PRIMEZONE) -- atugen AG (GER:ATUG), a Berlin-based functional genomics company, and one of the leaders in the field of therapeutic gene discovery and validation,...

STOCKHOLM, Sweden, Sept. 6, 2001 (PRIMEZONE) -- SEK (SSE:SEK) has launched a CHF 250 million bond, with UBS AG, Zurich as lead manager. This issue is sold to institutional, as well as, retail...

STOCKHOLM, Sweden, Sept. 6, 2001 (PRIMEZONE) -- SEK (SSE:SEK) has launched a DKK 400 million bond with KBC Bank and Fortis Bank as joint lead managers. This issue is primarily sold to retail...

OSLO, Norway, Sept. 5, 2001 (PRIMEZONE) -- After the merger between the Dutch Unit 4 and Agresso Group ASA (OSE:AGR) in December 2000, changes have been made in the organization. Unit 4 Agresso NV is...

DUBLIN, Ireland, Sept. 4, 2001 (PRIMEZONE) -- Parthus Technologies plc (Nasdaq:PRTH) (LSE:PRH), a leading provider of platform level intellectual property (IP), today announced a licensing agreement...

CAMBRIDGE, UK, Sept. 3, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN.L) today announced the appointment of Mr. Dan Welch to the Board as a non-executive director. Dan Welch, currently...